BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23835284)

  • 1. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Food Chem Toxicol; 2013 Dec; 62():A1-4. PubMed ID: 23835284
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen OP; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes A; Gooderham N; Harvey A
    Toxicol In Vitro; 2013 Oct; 27(7):2110-4. PubMed ID: 23850741
    [No Abstract]   [Full Text] [Related]  

  • 3. Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles.
    Dietrich D; von Aulock S; Marquardt HW; Blaauboer BJ; Dekant W; Kehrer J; Hengstler JG; Collier AC; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Arch Toxicol; 2013 Sep; 87(9):1739-41. PubMed ID: 23979651
    [No Abstract]   [Full Text] [Related]  

  • 4. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dekant W; Kehrer JP
    Toxicol Lett; 2013 Nov; 223(2):A1-4. PubMed ID: 23916789
    [No Abstract]   [Full Text] [Related]  

  • 5. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; Aulock Sv; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Barile FA; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Chem Biol Interact; 2013 Sep; 205(1):A1-5. PubMed ID: 23832050
    [No Abstract]   [Full Text] [Related]  

  • 6. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A; Barile FA
    Toxicon; 2013 Dec; 76():A1-A2. PubMed ID: 24409469
    [No Abstract]   [Full Text] [Related]  

  • 7. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Batta Gori G; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Wallace Hayes A; Gooderham N; Harvey A
    ALTEX; 2013; 30(3):381-5. PubMed ID: 23861084
    [No Abstract]   [Full Text] [Related]  

  • 8. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; Aulock SV; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A; Barile FA
    Toxicon; 2013 Dec; 76():A1-A2. PubMed ID: 24512766
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk assessment of endocrine disrupting chemicals--introduction to this special issue.
    van Ravenzwaay B; Dekant W; Vrijhof H
    Toxicol Lett; 2013 Dec; 223(3):269-70. PubMed ID: 24140152
    [No Abstract]   [Full Text] [Related]  

  • 10. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
    Gori GB; Dekant W
    Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.
    Bergman Å; Andersson AM; Becher G; van den Berg M; Blumberg B; Bjerregaard P; Bornehag CG; Bornman R; Brandt I; Brian JV; Casey SC; Fowler PA; Frouin H; Giudice LC; Iguchi T; Hass U; Jobling S; Juul A; Kidd KA; Kortenkamp A; Lind M; Martin OV; Muir D; Ochieng R; Olea N; Norrgren L; Ropstad E; Ross PS; Rudén C; Scheringer M; Skakkebaek NE; Söder O; Sonnenschein C; Soto A; Swan S; Toppari J; Tyler CR; Vandenberg LN; Vinggaard AM; Wiberg K; Zoeller RT
    Environ Health; 2013 Aug; 12():69. PubMed ID: 23981490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
    Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Commission tables scientific criteria for endocrine disruptors.
    Watson R
    BMJ; 2016 Jun; 353():i3459. PubMed ID: 27328830
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose.
    Day P; Green RM; Gross M; Weltje L; Wheeler JR
    Toxicol Lett; 2018 Oct; 296():10-22. PubMed ID: 30006252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the population relevance of endocrine-disrupting effects for nontarget vertebrates exposed to plant protection products.
    Crane M; Hallmark N; Lagadic L; Ott K; Pickford D; Preuss T; Thompson H; Thorbek P; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2019 Mar; 15(2):278-291. PubMed ID: 30520244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
    Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
    SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science and regulation. New science for chemicals policy.
    Schwarzman MR; Wilson MP
    Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.